The Journal of Immunology · 2013 · 218 citations · 54 references
Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesInnate ImmunityVaccinologyAntibody CharacterizationAntibody-mediated ProtectionAntiviral ImmunityHumoral ImmunityNatural Killer Cell BiologyViral VaccinesAntibody-dependent Cell-mediated CytotoxicityAntibody-dependent Cellular CytotoxicityAntibody-mediated Viral NeutralizationAntibody-mediated Virus NeutralizationAvian Influenza VirusCross-protective ImmunityEliminationNeutralizing Antibody Assays
A better understanding of immunity to influenza virus is needed to generate cross-protective vaccines. Engagement of Ab-dependent cellular cytotoxicity (ADCC) Abs by NK cells leads to killing of virus-infected cells and secretion of antiviral cytokines and chemokines. ADCC Abs may target more conserved influenza virus Ags compared with neutralizing Abs. There has been minimal interest in influenza-specific ADCC in recent decades. In this study, we developed novel assays to assess the specificity and function of influenza-specific ADCC Abs. We found that healthy influenza-seropositive young adults without detectable neutralizing Abs to the hemagglutinin of the 1968 H3N2 influenza strain (A/Aichi/2/1968) almost always had ADCC Abs that triggered NK cell activation and in vitro elimination of influenza-infected human blood and respiratory epithelial cells. Furthermore, we detected ADCC in the absence of neutralization to both the recent H1N1 pandemic strain (A/California/04/2009) as well as the avian H5N1 influenza hemagglutinin (A/Anhui/01/2005). We conclude that there is a remarkable degree of cross-reactivity of influenza-specific ADCC Abs in seropositive humans. Targeting cross-reactive influenza-specific ADCC epitopes by vaccination could lead to improved influenza vaccines.
54
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert, Gira Bhabha, Marc‐André Elsliger et al. · Science · 2009 · 1.4K citations · Full text